Radiological and Molecular Analysis of Radioiodinated Anastrozole and Epirubicin as Innovative Radiopharmaceuticals Targeting Methylenetetrahydrofolate Dehydrogenase 2 in Solid Tumors
In the dynamic field of radiopharmaceuticals, innovating targeted agents for cancer diagnosis and therapy is crucial. Our study enriches this evolving landscape by evaluating the potential of radioiodinated anastrozole ([<sup>125</sup>I]anastrozole) and radioiodinated epirubicin ([<su...
Saved in:
Main Author: | Mazen Abdulrahman Binmujlli (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lysine Decorated Solid Lipid Nanoparticles of Epirubicin for Cancer Targeting and Therapy
by: Parvaneh Bayat, et al.
Published: (2021) -
Design and Optimization of Sesamol Nanosuspensions to Potentiate the Anti-Tumor Activity of Epirubicin against Ehrlich Solid Carcinoma-Bearing Mice
by: Kholoud A. Elzanaty, et al.
Published: (2024) -
Innovative Radiopharmaceuticals in Oncology and Neurology
by: Michel Cherel
Published: (2017) -
Association of a Polymorphism in the Gene Encoding Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) 1958G>A with Orofacial Cleft
by: Elza Ibrahim Auerkari, et al.
Published: (2021) -
Effects of psoralen on the pharmacokinetics of anastrozole in rats
by: Yuzhu Zhang, et al.
Published: (2018)